EMPASHIELD 25 10'S

About

Empashield 25 contains Empagliflozin, an oral antidiabetic medication classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It functions by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose from the filtered blood back into the bloodstream. By blocking this action, Empagliflozin promotes the excretion of excess glucose through the urine, thereby lowering blood glucose levels in an insulin-independent manner. This mechanism makes it an effective treatment for type 2 diabetes mellitus.

Beyond its glucose-lowering effects, Empagliflozin has demonstrated significant cardiovascular and renal benefits. Clinical trials have shown that it reduces the risk of cardiovascular death, hospitalization for heart failure, and the progression of kidney disease in patients with type 2 diabetes who also have established cardiovascular disease or chronic kidney disease. These pleiotropic effects contribute to improved long-term outcomes for patients by addressing multiple aspects of metabolic and cardiovascular health.

Uses

• Management of type 2 diabetes mellitus.
• Reduction of cardiovascular death risk in type 2 diabetes patients with established cardiovascular disease.
• Reduction of hospitalization for heart failure in type 2 diabetes patients.
• Slowing the progression of chronic kidney disease in certain patients.

Directions For Use

Take orally once daily in the morning, with or without food, as directed by your physician. Swallow the tablet whole with water.

Benefits

• Effectively lowers blood glucose levels.
• Reduces risk of cardiovascular death.
• Decreases hospitalizations for heart failure.
• Provides renal protective effects.
• May lead to modest weight loss.
• Low risk of hypoglycemia when used alone.

Side Effects

• Urinary tract infections (UTIs)
• Genital yeast infections
• Increased urination
• Thirst
• Nausea
• Constipation
• Dizziness
• Hypotension (low blood pressure)
• Ketoacidosis (rare but serious)
• Acute kidney injury
• Fournier's gangrene (very rare)
• Allergic reactions

Safety Measures

• Alcohol - Limit alcohol intake as it can increase the risk of ketoacidosis and dehydration, especially when combined with this medication.
• Pregnancy - Generally not recommended during pregnancy, particularly in the second and third trimesters, due to potential adverse effects on fetal kidney development. Consult a doctor.
• Breastfeeding - Not recommended during breastfeeding as it is unknown if the drug passes into breast milk and could harm the infant. Consult a doctor.
• Liver - Use with caution in patients with severe liver impairment; dose adjustments may be necessary.
• Kidney - Not recommended for patients with severe kidney impairment (eGFR below a certain threshold) due to reduced efficacy and increased risk of adverse effects.
• Lung - Generally safe for use in patients with lung conditions; no specific contraindications related to pulmonary function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.